[Debate: Preventive coronary intervention for vulnerable plaque. The interventional cardiologist's approach].
作者信息
Gómez-Lara Josep
机构信息
Departamento de Cardiología, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, España Departamento de Cardiología, Hospital Universitari de Bellvitge Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Universitat de Barcelona, L'Hospitalet de Llobregat Barcelona España.
出版信息
REC Interv Cardiol. 2024 Oct 16;7(1):54-56. doi: 10.24875/RECIC.M24000485. eCollection 2025 Jan-Mar.
Abstract
摘要
相似文献
1
[Debate: Preventive coronary intervention for vulnerable plaque. The interventional cardiologist's approach].
REC Interv Cardiol. 2024 Oct 16;7(1):54-56. doi: 10.24875/RECIC.M24000485. eCollection 2025 Jan-Mar.
2
[Debate: Preventive coronary intervention for vulnerable plaque. The clinical cardiologist's approach].
REC Interv Cardiol. 2024 Oct 16;7(1):51-53. doi: 10.24875/RECIC.M24000486. eCollection 2025 Jan-Mar.
3
Cardiac Computed Tomography Angiography in the Evaluation of Coronary Artery Disease: An Interventional Perspective.
J Soc Cardiovasc Angiogr Interv. 2024 Mar 26;3(3Part B):101301. doi: 10.1016/j.jscai.2024.101301. eCollection 2024 Mar.
4
Cardiologist's exposure to radiation in cath lab measured with Instadosedosimeter.
J Radiol Prot. 2023 Feb 17;43(1). doi: 10.1088/1361-6498/acb82b.
5
[Debate. "Orbiting" around the management of stable angina. The interventional cardiologist's perspective].
REC Interv Cardiol. 2024 Apr 17;6(3):235-237. doi: 10.24875/RECIC.M24000453. eCollection 2024 Jul-Sep.
6
[Debate. Asymptomatic severe aortic stenosis: when should we intervene? The interventional cardiologist's perspective].
REC Interv Cardiol. 2023 Nov 2;6(1):43-45. doi: 10.24875/RECIC.M23000419. eCollection 2024 Jan-Mar.
7
The impact of the distance from the interventional cardiologist's home to the hospital during off hours.
Catheter Cardiovasc Interv. 2014 Nov 15;84(6):950-4. doi: 10.1002/ccd.25492. Epub 2014 Apr 16.
8
A non-interventional cardiologist's guide to coronary chronic total occlusions.
Front Cardiovasc Med. 2024 Feb 6;11:1350549. doi: 10.3389/fcvm.2024.1350549. eCollection 2024.
9
Revascularization of patients with coronary artery disease: the interventional cardiologist's perspective.
Ann Thorac Surg. 1997 Jun;63(6 Suppl):S23-7. doi: 10.1016/s0003-4975(97)00438-4.
10
Lipid-lowering therapy after coronary revascularization: the interventional cardiologist's perspective.
Am J Cardiol. 1998 Apr 9;81(7A):55E-62E. doi: 10.1016/s0002-9149(98)00199-4.
本文引用的文献
1
Paclitaxel-coated balloons for vulnerable lipid-rich plaques.
EuroIntervention. 2024 Jul 1;20(13):e826-e830. doi: 10.4244/EIJ-D-23-01073.
2
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
Lancet. 2024 May 4;403(10438):1753-1765. doi: 10.1016/S0140-6736(24)00413-6. Epub 2024 Apr 8.
3
Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years.
J Am Coll Cardiol. 2023 Nov 28;82(22):2069-2083. doi: 10.1016/j.jacc.2023.09.814.
4
Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in Spain.
Atherosclerosis. 2023 Jun;375:38-44. doi: 10.1016/j.atherosclerosis.2023.04.013. Epub 2023 May 11.
5
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
JAMA. 2022 May 10;327(18):1771-1781. doi: 10.1001/jama.2022.5218.
6
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
7
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque.
J Am Coll Cardiol. 2020 Nov 17;76(20):2289-2301. doi: 10.1016/j.jacc.2020.09.547. Epub 2020 Oct 15.
8
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.
Eur Heart J. 2020 Jan 14;41(3):347-356. doi: 10.1093/eurheartj/ehz660.
9
Impact of statins on serial coronary calcification during atheroma progression and regression.
J Am Coll Cardiol. 2015 Apr 7;65(13):1273-1282. doi: 10.1016/j.jacc.2015.01.036.
10
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
EuroIntervention. 2015 Nov;11(7):746-56. doi: 10.4244/EIJY14M10_06.
Zotero 插件